267 related articles for article (PubMed ID: 11365956)
1. Fomivirsen approved for CMV retinitis.
Roehr B
J Int Assoc Physicians AIDS Care; 1998 Oct; 4(10):14-6. PubMed ID: 11365956
[TBL] [Abstract][Full Text] [Related]
2. Fomivirsen approved for CMV retinitis: first antisense drug.
AIDS Treat News; 1998 Sep; (302):7. PubMed ID: 11365764
[TBL] [Abstract][Full Text] [Related]
3. Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
Orr RM
Curr Opin Mol Ther; 2001 Jun; 3(3):288-94. PubMed ID: 11497353
[TBL] [Abstract][Full Text] [Related]
4. New CMV retinitis drug approved.
Body Posit; 1998 Oct; 11(10):10. PubMed ID: 11365907
[TBL] [Abstract][Full Text] [Related]
5. Advances in CMV management: fomivirsen (Vitravene) approved.
Proj Inf Perspect; 1998 Dec; (26):7. PubMed ID: 11366499
[TBL] [Abstract][Full Text] [Related]
6. New CMV drug won't replace other therapies.
AIDS Alert; 1998 Nov; 13(11):124-6. PubMed ID: 11365968
[TBL] [Abstract][Full Text] [Related]
7. FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.
Highleyman L
BETA; 1998 Oct; ():5. PubMed ID: 11365993
[TBL] [Abstract][Full Text] [Related]
8. Fomivirsen.
Highleyman L
BETA; 1998 Apr; ():29, 31. PubMed ID: 11365261
[TBL] [Abstract][Full Text] [Related]
9. Cidofovir recommended for approval for CMV retinitis.
James JS
AIDS Treat News; 1996 Apr; (no 244):6-7. PubMed ID: 11363308
[TBL] [Abstract][Full Text] [Related]
10. First eye implant approved.
AIDS Alert; 1996 May; 11(5):59. PubMed ID: 11363254
[TBL] [Abstract][Full Text] [Related]
11. FDA approves cidofovir for treatment of CMV retinitis. Food and Drug Administration.
J Int Assoc Physicians AIDS Care; 1996 Aug; 2(8):30. PubMed ID: 11363758
[TBL] [Abstract][Full Text] [Related]
12. Fomiversen sodium approved to treat CMV retinitis.
Piascik P
J Am Pharm Assoc (Wash); 1999; 39(1):84-5. PubMed ID: 9990192
[No Abstract] [Full Text] [Related]
13. Fomivirsen approved.
AIDS Patient Care STDS; 1998 Dec; 12(12):943. PubMed ID: 11362071
[No Abstract] [Full Text] [Related]
14. Vitravene--another piece in the mosaic.
Crooke ST
Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):vii-viii. PubMed ID: 9743463
[No Abstract] [Full Text] [Related]
15. First oligonucleotide in U.S. clinical trials for CMV retinitis.
AIDS Patient Care STDS; 1997 Jun; 11(3):198-9. PubMed ID: 11361805
[No Abstract] [Full Text] [Related]
16. FDA notifications. FDA approves generic foscarnet sodium injection.
AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16110563
[No Abstract] [Full Text] [Related]
17. Foscavir receives new indication.
AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
[TBL] [Abstract][Full Text] [Related]
18. Isis presents data on safety and effectiveness of antisense CMV retinitis compound.
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363533
[TBL] [Abstract][Full Text] [Related]
19. FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration.
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363532
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS.
Vitravene Study Group
Am J Ophthalmol; 2002 Apr; 133(4):467-74. PubMed ID: 11931780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]